Genital tubercle
|
WikiDoc Resources for Genital tubercle |
|
Articles |
|---|
|
Most recent articles on Genital tubercle Most cited articles on Genital tubercle |
|
Media |
|
Powerpoint slides on Genital tubercle |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Genital tubercle at Clinical Trials.gov Trial results on Genital tubercle Clinical Trials on Genital tubercle at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Genital tubercle NICE Guidance on Genital tubercle
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Genital tubercle Discussion groups on Genital tubercle Patient Handouts on Genital tubercle Directions to Hospitals Treating Genital tubercle Risk calculators and risk factors for Genital tubercle
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Genital tubercle |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
A genital tubercle is a body of tissue present in the development of the urinary and reproductive organs. It forms in the ventral, caudal region of mammalian embryos of both sexes, and eventually develops into a phallus. In the human fetus the genital tubercle develops around week 4 of gestation, and by week 9 becomes recognizably either a clitoris or penis.
Even after the phallus is developed, the term genital tubercle remains, but only as the terminal end of it[1], which develops into either the glans penis or the glans clitoridis.
The genital tubercle is sensitive to dihydrotestosterone and rich in 5-alpha-reductase, so that the amount of fetal testosterone present after the second month is a major determinant of phallus size at birth.